Solentim is the trusted global leader for solutions to create, isolate, and characterize the highest value cells for the development of new biological medicines, including cell and gene therapies, monoclonal antibodies, vaccines and stem cells. For our customers, which include most of the world’s leading pharmaceutical and biotherapeutics companies, we are the partner of choice for facilitating the highest level of assurance in cell line development for therapeutic protein and viral vector production.
Our customers develop cell and antibody based therapies for a wide range of conditions including lymphomas, cancers, Crohn’s disease, rheumatoid arthritis, high cholesterol and asthma.
Our portfolio of proven and innovative instruments (including VIPS™, Cell Metric®, Cell Metric® CLD, ICON™ and STUDIUS™) are designed for single cell cloning and assurance of monoclonality. Combined with enabling reagents and our unparalleled domain expertise, we transform the speed and efficiency of clonally-derived Master Cell Bank development. Our customers trust in our technology to ensure they are confidently prepared for regulatory review.
Solentim continues to define modern assurance driven workflows for cell based and antibody based biotherapeutics including stem cells, gene therapy and immunotherapy.
Experience & Expertise
We are a global company with staff based in Europe, Asia and the USA. Our products are used by pharmaceutical and biotech companies all over the world. We are a fast growing, innovative organisation with a strong team of highly-skilled, talented individuals working together in a friendly, creative and fast-paced, environment – all striving to make a difference to the lives of patients.
Please get in touch to talk to an expert about your area of work.
Sign up to our newsletter...
Keep updated on out latest product news, events, webinars and regular updates